AKT1 and non-small cell lung carcinoma: Similarly, Notch or AKT inhibition reduced levels of miR-223 in NSCLC cell lines resistant to the anti-EGFR agent erlotinib, whereas suppression of miR-223 sensitized cells to this kinase inhibitor by increasing expression of FBXW7 [318].